DEA suspends distribution license.
On April 24, 2007, AmerisourceBergen Corp (NYSE: ABC, BullBoards) disclosed that the U.S. Drug Enforcement Administration (DEA) had temporarily suspended its Orland, Florida Distribution Center's license to distribute DEA-controlled substances and listed chemicals. Specifically, the DEA believed that the cough suppressant and painkiller hydrocodone was improperly sold to four Internet pharmacies. The DEA asserted that AmerisourceBergen did not maintain effective controls against the diversion of controlled substances, specifically hydrocodone, to four internet pharmacies from January 1, 2006 to January 31, 2007.
It appears that investors who purchased AmerisourceBergen Corp. shares between January 1, 2006 and April 24, 2007 may be affected.
IPO Troubles for Allot Communications Investors
In its Registration Statement and Prospectus, Allot Communications Ltd. (NASDAQ:ALLT, BullBoards) represented that it would achieve its goal of becoming the leader in its industry through its ability to market and sell its products to end-customers through its channel partners. In fact, it now appears that at the time of the IPO, Allot was experiencing declining sales in its indirect distribution channels, such as enterprise, education and smaller ISP customers, in North America.
Specifically, in February 2006, Allot represented to investors that the company expected net revenues for the first quarter of 2007, which is traditionally slow in its sector, to be similar to the revenue level for fourth quarter 2006, with growth to resume in the second quarter of 2007 and continue through the remainder of the year. It expected earnings per diluted share for the first quarter of 2007 to be similar to the fourth quarter of 2006. For the fiscal year 2007, the Allot anticipated net revenue in the range of $43-$47 million, with earnings per diluted share, excluding the effect of share-based compensation, of between 27 and 33 cents per share.
Then, on April 2, 2007, Allot issued a press release announcing that revenues and
earnings for the first quarter of 2007 and the 2007 fiscal year would be materially lower than its previous guidance. Allot explained that "weakness in sales from some of the company's distributors, principally in the Americas, which are focused on sales to enterprise, education, and smaller ISPs, had resulted in lower than expected revenues."
In response to the company's revised guidance, on April 2,
2007, the price of Allot stock declined from $9.15 per share to $7.11 per share - approximately 40% below the IPO price - on heavier than usual volume.
Investors who purchased the common stock of Allot pursuant to the company's initial public offering on or about November 15, 2006 may be affected..
Mark McNair is an attorney in private practice who represents investors in securities litigation and was formerly an attorney at the Securities and Exchange Commission. For additional information, go to securitiessleuth.com
StockHouse Conflict and Disclosure Policy:
Stockgroup Media Inc., owners and operators of StockHouse.ca/com, has established rules to ensure that there is no appearance of impropriety on the part of any StockHouse writers who discuss or name individual public companies in the content published on the StockHouse websites. The content of StockHouse Editorial articles are the opinion of the writer and any reliance on the content of these articles shall be at your sole risk.
StockHouse Editorial writers may own, buy, or sell shares in public companies mentioned in their articles. Please be advised that a conflict may exist and that any investment decisions you make are your own responsibility. Additionally, our Editorial writers are not registered investment advisors. You should not make any kind of investment decision in relation to these articles or stocks discussed in them without first obtaining independent investment advice from a registered investment advisor.
Facts relied upon by our Editorial writers in arriving at their opinions are generally provided by the subject companies or gathered by our Editorial writers from other public and/or private sources. These facts may be in error and if so, the opinions of our Editorial writers may be materially different.
Rules applying to StockHouse Editorial Writers
StockHouse Editorial writers may own stock of any company they cover, but at the bottom of the article or within the article they must clearly and prominently state their ownership position in the company.
StockHouse Editorial writers cannot solicit, accept, or agree to receive anything of value given or paid with the intent of influencing their editorial articles published on StockHouse.
StockHouse Editorial writers are not permitted to write articles that attempt to influence or benefit persons connected to the writer such as family or friends, , except where disclosure is made in the same way as if the writer him/herself owns stock.
StockHouse notifies each Editorial writer about these rules but in case of a possible breach of our rules, we may not be in a position to find out or investigate the facts. We rely on the integrity of our writers to ensure that our rules are followed.